IDACIO

This brand name is authorized in Albania, Australia, Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Spain, UK.

Active ingredients

The drug IDACIO contains one active pharmaceutical ingredient (API):

1	Adalimumab UNII FYS6T7F842 - ADALIMUMAB
	Adalimumab binds specifically to TNF and neutralizes the biological function of TNF by blocking its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab also modulates biological responses that are induced or regulated by TNF, including changes in the levels of adhesion molecules responsible for leukocyte migration (ELAM-1, VCAM-1, and ICAM-1 with an IC50 of 0.1-0.2 nM).
	Read more about Adalimumab

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
IDACIO Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AB04	Adalimumab	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AB Tumor necrosis factor alpha (TNF-α) inhibitors
Discover more medicines within L04AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	664/48, 664/48a
AU	Pharmaceutical Benefits Scheme	10399H, 10400J, 10412B, 10413C, 10419J, 10420K, 10944B, 10955N, 10960W, 10961X, 12325Q, 12326R, 12327T, 12328W, 12329X, 12330Y, 12331B, 12333D, 12334E, 12348X, 12352D, 12353E, 12355G, 12356H, 12365T, 12366W, 12367X, 12368Y, 12369B, 12370C, 12384T, 12385W, 12386X, 12387Y, 12388B, 12401Q, 12402R, 12403T, 12415K, 12416L, 12420Q, 12434K, 12437N, 12438P, 5281Y, 5282B, 5283C, 5284D, 8737W, 8741C, 8963R, 8964T, 8965W, 8966X, 9033K, 9034L, 9077R, 9078T, 9099X, 9100Y, 9101B, 9102C, 9103D, 9104E, 9188N, 9189P, 9190Q, 9191R, 9425C, 9426D, 9427E, 9428F, 9662M, 9663N, 9679K, 9680L
BR	Câmara de Regulação do Mercado de Medicamentos	509520120028107, 509520120028207, 509520120028307
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	15396239, 15396245, 15396251, 15434514, 15434520, 16146674, 16146680, 16146697, 16146705, 16150859, 16150865, 16150871, 16150888, 16206206, 16206235, 16206241, 16206258, 16227711, 16227728, 16395288, 16395294, 16581648, 16790352, 16801185, 16801191, 16811930, 16811947, 16838165, 16838188, 16856571, 16879715, 16924456, 17249005, 17249011, 17249028, 17249040, 17598906, 17598912, 17875317
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	204-MBE-0621
EE	Ravimiamet	1792560, 1792571, 1792593, 1821732, 1821743
ES	Centro de información online de medicamentos de la AEMPS	1191356001, 1191356002, 1191356003
FI	Lääkealan turvallisuus- ja kehittämiskeskus	110046, 571259, 579764
FR	Base de données publique des médicaments	63592177, 64202598, 65837903
GB	Medicines & Healthcare Products Regulatory Agency	383645, 383664, 383669
HK	Department of Health Drug Office	67220, 67221
IE	Health Products Regulatory Authority	88800, 88816, 88817
IL	מִשְׂרַד הַבְּרִיאוּת	8871
IT	Agenzia del Farmaco	047805015, 047805027, 047805039, 047805041, 047805054
LT	Valstybinė vaistų kontrolės tarnyba	1087487, 1087488, 1087489, 1088432, 1088433
NL	Z-Index G-Standaard, PRK	106348, 197807, 84492
NZ	Medicines and Medical Devices Safety Authority	20956, 20987
PL	Rejestru Produktów Leczniczych	100419865, 100419871, 100419888
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65919001, W65920001, W65921001